Kalekim Kimyevi Maddeler Sanayi & Ticaret AS Cash Flow Reinvestment Rate
Kalekim Kimyevi Maddeler Sanayi & Ticaret AS cash flow reinvestment rate. Kalekim Kimyevi Maddeler Sanayi & Ticaret AS (KLKIM) has a Cash Flow Reinvestment Rate of 0.27x as of December 2025, reinvesting TL221.96 Million (capex TL221.96 Million ) from operating cash flow of TL822.16 Million. See KLKIM FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Kalekim Kimyevi Maddeler Sanayi & Ticaret AS (2019–2025)
Cash flow reinvestment rate of Kalekim Kimyevi Maddeler Sanayi & Ticaret AS from 2019 to 2025. Historical reinvestment intensity for Kalekim Kimyevi Maddeler Sanayi & Ticaret AS across 7 annual periods. Explore how well can Kalekim Kimyevi Maddeler Sanayi & Ticare service its debt to assess how comfortably operating cash covers total debt obligations.
Kalekim Kimyevi Maddeler Sanayi & Ticaret AS Cash Flow Reinvestment Rate by Year (2019–2025)
Kalekim Kimyevi Maddeler Sanayi & Ticaret AS cash flow reinvestment rate by year from 2019 to 2025. Year-by-year capital reinvestment analysis for Kalekim Kimyevi Maddeler Sanayi & Ticaret AS. For the full cash flow conversion analysis, see KLKIM cash generation efficiency.
| Year | Reinvestment Rate | Total Reinvested (TRY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.42x | TL834.11 Million | TL1.97 Billion | TL834.11 Million | ▼ -68.4% |
| 2024 | 1.34x | TL1.15 Billion | TL854.98 Million | TL597.20 Million | ▼ -2.4% |
| 2023 | 1.37x | TL978.32 Million | TL712.33 Million | TL507.10 Million | ▲ +263.7% |
| 2022 | 0.38x | TL95.38 Million | TL252.62 Million | TL87.57 Million | ▲ +52.5% |
| 2021 | 0.25x | TL49.74 Million | TL200.94 Million | TL47.81 Million | ▲ +5.8% |
| 2020 | 0.23x | TL28.04 Million | TL119.80 Million | TL25.48 Million | ▲ +33.6% |
| 2019 | 0.18x | TL17.19 Million | TL98.15 Million | TL14.63 Million | — |